DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Demetri G, Desai J, Fletcher JA, Morgan JA, Fletcher CDM, Kazanovicz A, van den Abbeele A, Baum C, Maki R, Heinrich M.
SU11248, a multi-targeted tyrosine kinase inhibitor, can overcome imatinib (IM) resistance caused by diverse genomic mechanisms in patients (pts) with metastatic gastrointestinal stromal tumor (GIST).
Proc Am Soc Clin Oncol 2004; 22(14S): 3001-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.